Last reviewed · How we verify
Pain Cocktail with Exparel — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Pain Cocktail with Exparel (Pain Cocktail with Exparel) — DeClaire LaMacchia Orthopaedic Institute.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pain Cocktail with Exparel TARGET | Pain Cocktail with Exparel | DeClaire LaMacchia Orthopaedic Institute | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pain Cocktail with Exparel CI watch — RSS
- Pain Cocktail with Exparel CI watch — Atom
- Pain Cocktail with Exparel CI watch — JSON
- Pain Cocktail with Exparel alone — RSS
Cite this brief
Drug Landscape (2026). Pain Cocktail with Exparel — Competitive Intelligence Brief. https://druglandscape.com/ci/pain-cocktail-with-exparel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab